Legal Representation
Attorney
Maury M. Tepper, III
USPTO Deadlines
Next Deadline
1 days remaining
Notice of Publication
Due Date
July 10, 2025
Extension Available
Until August 10, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
12 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 10, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jun 10, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jun 4, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| May 6, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| May 6, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| May 6, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| May 6, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| May 6, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Apr 30, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 1, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Apr 1, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Apr 1, 2025 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations and gene therapy products in the nature of injectable biological preparations for the treatment of genetic, neurological, motor neuron, and neuromuscular diseases, disorders, and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials, sold as a unit, for the treatment of spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparations in the nature of biological preparations containing genetic materials, sold as a unit, for sustained survival motor neuron protein expression being for the treatment of spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"INTRATHECAL"